Sweet Peach Founder Speaks: Those Startup Dudes Were Wrong About My Company
By Jeff Bercovici,
Inc
| 11. 21. 2014
Untitled Document
When I wrote earlier this week about a new probiotic supplement called Sweet Peach engineered to make women's vaginas smell like fruit, the response across the internet was understandable outrage: Who the hell were the guys behind this and what right did they have to decide how women's bodies ought to smell?
But the true story of Sweet Peach is outrageous in a different way. It turns out that the "startup dudes" who introduced it to the world at the DEMO tech conference, biotech entrepreneurs Austen Heinz and Gilad Gome, are not its creators, and the way they characterized it was highly misleading.
The sole founder and CEO of Sweet Peach Probiotics is a 20-year-old woman named Audrey Hutchinson. A former college student at Bard, where she studied on a full-ride Distinguished Scientist scholarship, she describes herself as an "ultrafeminist" who dropped out to pursue her vision of helping women manage their reproductive health without the need for doctors or clinics. "I don't think women should have vaginas that smell like peaches or anything like that," she...
Related Articles
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Philip Ball , Nature | 06.17.2026
Our genomes are full of mutations that have the potential to damage our health or even kill us. Yet most of them rarely cause problems. Why? It’s partly thanks to a family of proteins that mask, or ‘buffer’, the ill...
By Philip Ball, Quanta Magazine | 06.18.2026
Since its molecular structure was deduced in the 1950s, DNA has been hailed by many biologists as the secret of life. They’ve read and studied the information stored in the DNA found in the cells of living organisms, known as...
By Arche Noah, GMWatch | 06.17.2026
The European Parliament has voted for a wide-reaching deregulation of New Genomic Techniques (NGTs). There was no majority for amendments stopping patents on conventionally classically bred plants or NGT plants. “Today’s vote is a missed opportunity to protect Europe’s farmers...